Evaluation of canarypox-induced CD8(+) responses following immunization by measuring the effector population IFNgamma

T G Evans1, E G Kallas, M Campbell

  • 1Infectious Diseases Unit, Suite 500, Department of Medicine, University of Rochester School of Medicine and Dentistry, PSSB 4150 V St., Sacramento, CA 95817, USA. tgevans@ucdavis.edu

Immunology Letters
|May 12, 2001
PubMed

Insights

Flow cytometry effectively measures CD8(+) interferon gamma (IFNγ) activity, a key indicator of cellular immune response to HIV-1 vaccines. This method shows promise for assessing vaccine efficacy and characterizing effector cells.

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • Traditional CD8(+) cytolytic activity assays using 51Cr release are complex.
  • Measuring intracellular interferon gamma (IFNγ) production via ELISPOT or flow cytometry offers an alternative for assessing CD8(+) T cell responses.
  • Assessing immune responses to novel HIV-1 vaccine candidates is crucial for public health.

Purpose of the Study:

  • To evaluate the utility of flow cytometry for measuring CD8(+) T cell-mediated IFNγ production in response to canarypox HIV-1 vaccines.
  • To compare the sensitivity of flow cytometry with traditional methods for detecting cellular immune responses.
  • To characterize the phenotype of effector cells involved in the vaccine-induced immune response.

Main Methods:

  • Phase 1 clinical trial involving 19 volunteers receiving canarypox HIV-1 vaccines (vCP205, vCP1433, vCP1452).
  • Peripheral blood mononuclear cells (PBMCs) were stimulated in vitro with vaccinia constructs encoding HIV-1 genes (env, gag) or a lacZ control.
  • Intracellular IFNγ production in CD8(+) T cells was measured using flow cytometry after co-incubation with infected target cells.

Main Results:

  • CD8(+) IFNγ activity was successfully measured in the majority of volunteers after four immunizations.
  • Specific responses to the gag gene varied across vaccine groups, with higher frequencies observed in vCP1433 and vCP1452 recipients.
  • Flow cytometry enabled simultaneous phenotyping of CD4 memory IFNγ production.

Conclusions:

  • Flow cytometry is a viable and promising method for measuring CD8(+) T cell-specific IFNγ responses to HIV-1 vaccines.
  • This technique facilitates the assessment of cellular immunity and the characterization of effector cell populations.
  • The findings support the use of flow cytometry as a surrogate measure for cytotoxic T lymphocyte (CTL) activity in vaccine trials.

Related Concept Videos